Objective. We aim to describe a novel, label-free, real-time imaging technique, coherent Raman scattering (CRS) microscopy, for histopathological evaluation of head and neck cancer. We evaluated the ability of CRS microscopy to delineate between tumor and nonneoplastic tissue in tissue samples from patients with head and neck cancer.
D espite advances in the diagnosis and treatment of head and neck carcinoma, it remains a formidable source of morbidity and mortality. In North America alone, more than 50,000 new cases of head and neck cancer are diagnosed yearly, and more than 12,000 deaths were estimated to occur due to head and neck cancer in 2015. 1 Most of these cancers are related to head and neck squamous cell carcinoma of the upper aerodigestive mucosa. 1 Tobacco and alcohol use are the main risk factors associated with the development of head and neck cancer, but the incidence of oropharyngeal cancer related to human papillomavirus (HPV) has been rising. 2 Due to its continued prevalence, morbidity, and mortality, head and neck carcinoma remains a major health problem in the world today.
Surgical intervention is a cornerstone of treatment for many head and neck cancers. In surgically treated head and neck cancer, margin status is one of the most important prognostic factors, with a positive surgical margin correlating with higher rates of local recurrence and lower rates of survival. 3 Unfortunately, in the head and neck, margins can be difficult to map and interpret due to the complex 3dimensional anatomy of the head and neck and close proximity of critical structures that cannot be resected. 3 While intraoperative frozen sections using hematoxylin and eosin (H&E) staining are widely accepted, there are downsides of this technique. Limitations include sampling errors between the margin, specimen, and resection bed, with discordance between whether or not to resect more ''normal tissue'' posing a difficult problem to the surgeon. 4, 5 In addition, studies on frozen-section analysis in head and neck carcinoma reveal the sensitivity to be between 83.1% to 88.8%, allowing for a false-negative rate that can result in unrecognized residual disease. [4] [5] [6] Finally, frozen-section analysis is time-consuming and resource consuming. It requires a functioning histopathology laboratory and extends the length of time the patient is under anesthesia while an experienced, in-facility histopathologist processes, stains, and evaluates the specimen.
Coherent Raman scattering (CRS) microscopy, which includes coherent anti-Stokes Raman scattering microscopy and stimulated Raman scattering (SRS) microscopy, is a unique label-free imaging technique that overcomes many of the limitations of standard microscopic methods. The CRS microscope analyzes the molecular composition of a sample by using the intrinsic vibrational characteristics of the various molecules, including lipids, proteins, and DNA, to provide contrast for the images. 7 The vibrational characteristics of CH 2 highlight lipid-rich structures, while the vibrational characteristics of CH 3 molecules highlight the protein-and DNA-rich structures, like nuclei, to create a virtual image. 8 Because CRS microscopy uses the intrinsic characteristics of these molecules, no processing, staining, or labeling is required, thereby increasing the efficiency of specimen evaluation.
CRS microscopy can also optically section specimens and thus can be used to evaluate even thick specimens, improving the ease of evaluating 3-dimensional surgical margins. Due to the nature of the microscope, specimens can be imaged at up to 30 frames per second, producing real-time microscopic tissue imaging that improves the rate of specimen evaluation. 9 This increased efficiency allows for streamlined specimen processing and could allow for improved accuracy in the delineation of tumor extent. Finally, because the images are digital, they can easily be stored, quality-controlled, and incorporated into infrastructure research databases and electronic medical records. In addition, should a facility not be equipped with a histopathology laboratory, images could be sent off site for realtime evaluation by a histopathologist.
CRS microscopy has been previously validated for use in neurosurgery for delineating tumor from nonneoplastic tissue. In these studies, CRS has excellent agreement with standard H&E imaging in assessing tumor infiltration. 10, 11 CRS microscopy has not previously been evaluated for use in identifying margin status in head and neck cancer or for use in diagnosing head and neck carcinomas. As a result, we evaluated the ability of CRS microscopy to delineate between tumor and nonneoplastic tissue in tissue samples from patients with head and neck cancer.
Methods
Eligible patients were surgical candidates with biopsyproven, previously untreated head and neck carcinoma. Patients were consented preoperatively for participation in this study, which was approved by the University of Michigan Institutional Review Board (HUM00095967 and HUM00042189). Tissue was obtained from 50 patients. Frozen margins were sent as the standard of care. Additional margins were taken based on the results of the H&E frozen margins only.
Tumor biopsy specimens and the normal controls were placed on slides, and no further processing, staining, or labeling was performed. We then used a 2-color stimulated Raman scattering microscopy method for imaging the human head and neck tumors. This microscope has previously been described in neurosurgical patients. 8 In brief, the microscope consists of a tunable pump beam (650-1000 nm), which is combined with a Stokes beam (1064 nm) from a fiber laser module tuned through the laser control module. The specimen is placed on the microscope stage of a fiber-coupled microscope, and these beams are then focused onto the sample. The sample causes an intensity loss in the pump beam, which correlates to the ratio of lipid and protein found in the sample. This intensity loss between the 2 beams is detected, and the variation in the lipid/protein ratio provides the contrast in the microscopic images, which is displayed on a computer ( Figure 1) .
Two separate scans are performed per field of view. For these scans, the Stokes beam is fixed at 1064 nm, and the other the beam is focused at either 2845 cm -1 , which highlights the characteristics of the CH 2 stretching vibrations, or 2940 cm -1 , which highlights the characteristics of the CH 3 stretching vibrations. CH 2 primarily highlights lipids in the cytoplasm, while the CH 3 image highlights lipids and proteins. The microscope scanning software acquires each image and then processes it via ImageJ (v1.49; National Institutes of Health, Bethesda, Maryland) ( Figure 2 ). Multiple consecutive fields of view are then collated and aligned to produce the final image.
To assess the ability of CRS microscopy to delineate between tumor and nonneoplastic tissue compared with the gold standard of H&E, tumor specimens were removed from the microscope slide after imaging and sent to the University of Michigan histopathology core for processing and H&E staining. The fixed specimens were randomized and then read independently as either tumor or normal tissue by a senior head and neck pathologist (J.B.M.). Patients were excluded if there was not gross tumor present in the H&E tumor specimen. Five tumor samples were shown by H&E to contain benign scar and normal tissue, and 3 tumor samples were shown by H&E to contain minimal cancer. Of the 50 patients, there were 42 tumor samples and 42 normal adjacent controls that were confirmed on H&E. The CRS images were randomized separately and then read by the same pathologist using a separate color lookup table. Results were tabulated, and the sensitivity and specificity of CRS were calculated using H&E as the gold standard. Images were classified in a binary fashion as ''tumor'' or ''normal.''
Results
Tumor characteristics are shown in Table 1 . Of the 42 confirmed carcinoma specimens, CRS microscopy successfully identified 37 as carcinoma. Of the 42 normal specimens, CRS microscopy successfully identified 40 as normal. This resulted in a sensitivity of 88.1% and specificity of 95.2% in distinguishing between neoplastic and nonneoplastic images ( Table 2) .
To understand the discordant cases in this study, we further examined the incorrectly identified tumor specimens. Three of the discordant specimens were imaged in the first month of imaging and retrospectively showed poor imaging quality due to user error while learning the process of CRS microscopy. During this time period, adaptation of CRS microscopy for head and neck tumors was occurring, and thus many of these specimens were not ideally sectioned for imaging with CRS microscopy. We realized that careful orientation and thinner sectioning of tissue produced higher quality images. If we eliminated the first month of specimens, this would remove 6 tumor samples, 3 of which showed discordance with CRS imaging. After development of a tissue-handling protocol that involved properly sectioning the specimens, the authors saw an increase in the efficiency and quality of the images produced, and sensitivity with these samples excluded would increase to 94.4%.
Discussion
In head and neck carcinoma, margin status is critically important to adequate treatment, as positive margin status correlates with higher risk of recurrence and decreased survival. 3 However, adequate margins are often difficult to obtain in the head and neck due to the complex anatomy as well as the close proximity of vital structures, such as the carotid artery, which cannot be resected. At this time, frozen margins are the gold standard for determining intraoperative margin status, but this technique still results in false negatives due to discordance between the margin, specimen, and surgical bed and adds operative time. In addition, an in-facility histopathology laboratory with welltrained histopathologists is critical to the accurate diagnosis of intraoperative frozen margins.
Here, we demonstrated in this early report that CRS microscopy can be used to differentiate between neoplastic and nonneoplastic tissue in head and neck carcinoma. CRS microscopy adequately demonstrates the atypical nuclei and hypercellularity characteristically seen in head and neck squamous cell carcinoma compared with H&E ( Figure 3) . In head and neck tumors, overall sensitivity was 88.1%, with a specificity of 95.2%. CRS microscopy was found to be easily performed and efficient, with acquisition and creation of the CRS slide taking less than 30 seconds.
CRS microscopy images were digital and thus could be easily transferred to the medical record or uploaded off-site for histopathology evaluation by a tertiary care center should a histopathologist not be present on-site or should a second opinion be required. Secondary evaluation of surgical pathology has been found in several studies to significantly affect treatment and diagnosis of patients with head and neck cancer, 12 and thus CRS microscopy could facilitate increased utilization of second opinions, even in real time, which could improve patient care.
Evaluation of CRS images, similar to H&E, requires training by the histopathologist. In addition, this study did not have the benefit of real-time margin acquisition, and when a sample that was imaged had poor tissue quality and thus was likely ''nondiagnostic,'' additional samples were not able to be obtained as occurs in standard frozen-margin evaluation. With further experience with CRS images and with the benefit of obtaining additional specimens should further tissue be required, we hypothesize that CRS microscopy would continue to demonstrate equal or improved sensitivity in diagnosing head and neck carcinoma compared with H&E staining. In addition, as we have discussed, CRS microscopy has the added benefit of creating digital images, which can facilitate second opinions and interfacility cooperation.
Due to its importance, multiple imaging techniques have been developed to evaluate margin status. Other imaging techniques, including optical coherence tomography 13 and confocal reflection, 14 have been evaluated for use in margin status but do not delineate nonneoplastic tissue from normal tissue as accurately as CRS microscopy. 10 In head and cancer, SRS has been evaluated for use in the detection of tumor infiltration in a few studies. [15] [16] [17] In one study in particular, scattered Raman spectroscopy was used to evaluate the lipid, connective tissue, and protein content of tissues, and then this was used to differentiate between tumor and normal tissue. This study laid the groundwork for Raman spectroscopy use in head and neck carcinoma as it did show promising results in the differentiation between normal and neoplastic tissue. 15 However, unlike coherent Raman spectroscopy, scattered Raman spectroscopy has long integration times, resulting in only point acquisition of images. In addition, due to the process of scattered Raman spectroscopy, SRS microscopy has poorer image quality that limits its translation into clinical applications. Finally, in cutaneous carcinoma, CRS microscopy has also been evaluated against standard H&E imaging and reflectance confocal microscopy (RCM). 18 RCM is currently the most widely used noninvasive high-resolution optical imaging technique, which has gained clinical acceptance for evaluation of cutaneous carcinomas. 18 Compared with these modalities in diagnosing cutaneous carcinomas, CRS was found to demonstrate the same level of detail and histopathological information as H&E-stained images and provided more detail than observed with RCM. 18 CRS microscopy has thus far shown substantial promise in its ability to be used clinically and has significant benefits over other imaging techniques.
Our group has also published on the use of CRS in the neurosurgical literature, with reported higher sensitivity of 97.5%. 10 The cellular differences between normal brain and tumor tissue allow a great contrast of normal and abnormal when examining brain tumors, which likely accounts for the improved resolution for these tissues. Squamous cell carcinoma and normal epithelium in the head and neck are both highly cellular, so this contrast is not as easily seen. We hope that in future studies, further fine tuning of the microscope will allow improved discrimination and better evaluate an accurate classifier for head and neck cancer.
An important limitation of this technology is the learning curve around tissue processing and using the microscope. Our first 6 samples required us to modify our technique, as we realized that careful orientation and thinner sectioning of tissue produced higher quality images. Studies on the frozensection analysis in head and neck carcinoma reveal the sensitivity to be between 83.1% and 88.8%, and with our improved processing technique, we were able to increase our sensitivity to 94.4%. [4] [5] [6] While this technology is increasingly being used in clinical scenarios, 19 a number of future studies must be performed before adding CRS microscopy to the clinical armamentarium. Future studies will require a larger prospective cohort to expand and validate this technology in head and neck cancer margins. Another important consideration will be to examine HPV-related malignancies, field cancerization effects, and dysplastic epithelium to determine the ability of CRS to distinguish between these commonly encountered tissues in head and neck pathology. In addition, future studies will examine the role of CRS microscopy in the diagnosis of other types of head and neck carcinoma that do not currently have an adequate method of obtaining intraoperative margins, such as melanoma. Finally, a study must be performed to evaluate whether CRS microscopy can be easily performed and interpreted by other fellowshiptrained head and neck pathologists with similar sensitivity and specificity rates.
Conclusion
CRS microscopy is a unique, label-free imaging technique that produces images demonstrating a similar sensitivity and specificity to routine H&E histopathology in determining carcinoma from benign tissue in this initial study after appropriate tissue-processing protocols were developed. It produces digital images that can be easily incorporated into an electronic medical record and could facilitate second opinions by an experienced histopathologist, thus improving patient care. CRS microscopy has the great potential to improve the efficiency and possibly the accuracy of margin status determination in head and neck cancer.
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